Among those with PrEP drug detected during infection , resistance was more frequent in the FTC/TDF arm ( 4 of 7 [ 57 % ] ) , compared with the TDF arm ( 1 of 19 [ 5.3 % ] ; P = .01 ) , owing to the FTC-associated mutation M184IV .